Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer.

Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Abstract Text:

    mark s walkerMark S Walker,damon j vidrineDamon J Vidrine,ellen r gritzEllen R Gritz,randy j larsenRandy J Larsen,yan yanYan Yan,ramaswamy govindanRamaswamy Govindan,edwin b fisherEdwin B Fisher,

    BACKGROUND: Non-small-cell lung cancer patients who continue to smoke after cancer diagnosis are more likely to experience disease recurrence, decreased treatment efficacy, and treatment complications. Despite this, many continue to smoke, with estimates ranging from 13% to approximately 60%. METHODS: Participants were 154 early-stage, non-small-cell lung cancer patients who had smoked within 3 months before surgery. Patients were followed for 12 months after surgery to assess smoking status and duration of continuous abstinence after surgery. Predictors included medical, smoking history, psychosocial, and demographic characteristics. RESULTS: At some point after surgery, 42.9% of patients smoked; at 12 months after surgery, 36.9% were smoking. Sixty percent of patients who lapsed did so during the first 2 months after surgery. Smoking at follow-up was predicted by shorter quit duration before surgery, more intense Appetitive cravings (expectation of pleasure from smoking), lower income, and having a higher level of education. Time until the first smoking lapse was predicted by shorter quit duration before surgery, more intense Appetitive cravings to smoke, and lower income. Among those who lapsed, greater delay before the lapse was associated with abstinence at the 12-month follow-up assessment. CONCLUSIONS: Nearly half of non-small-cell lung cancer patients return to smoking after surgery if they have recent smoking histories. Most initial lapses happen within 2 months and occur in response to more recent smoking and more intense cravings. Findings suggest that interventions to prevent relapse should target those who wait until cancer surgery to quit smoking and should be started as soon as possible after treatment.

    Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Publishing Authors By Initials

    ms walkerMS Walker,dj vidrineDJ Vidrine,er gritzER Gritz,rj larsenRJ Larsen,y yanY Yan,r govindanR Govindan,eb fisherEB Fisher,

    For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

    PUBMED ID PMID:

    MEDLINE DATE:

    Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Cancer epidemiology, biomarkers & prevention : a p

    VOLUME: 15

    Page Numbers: 2370-7

    Journal Abbreviation: Cancer Epidemiol. Biomarkers P

    ISSN: 1055-9965

    DAY: 28

    MONTH: 11

    YEAR: 2006

    Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9200608

    Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Keywords Mesh Terms:

    KEYWORDS: United States

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer.

    AFFILIATION: Department of Medicie, Washingon University School of Medicine, St. Louis, Missouri, USA. mwalker@im.wustl.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA85920

    ACRONYM: CA

    MEDLINETA: Cancer Epidemiol Biomarkers Pr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News